Adluri Uma Shankar Prasad, Tripathi Akash Chandra
Modern Medicine & Ayurveda, S.I.V.A.S Health & Research Institute, Sunshine Hospitals, Secunderabad, Telangana, India.
Chandra Prakash Ayurved Sansthan, Varanasi/Gorakhpur, India.
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100348. doi: 10.1016/j.jaim.2020.08.001. Epub 2020 Sep 8.
Epidemics have not been new to India. Ayurveda being in the fore front of health care of those times, has recorded its valuable experiences of epidemics & termed them as Janapadodhwamsa or Maraka. It has vividly described their mechanism of Causation (Nidana), factors affecting severity and actions complicating illnesses their management and prevention. The present work uses the same model described in Samhitas which assert the superiority of host susceptibility (Nija) over External Agent/Virus (Agantuja) and uses the same principles in prevention; while adopting the Jwara model to explain and correlate with different stages of COVID - 19. It proposes management guidelines using Ahara (Nutritional Principles) and Oushadha (Medication) for different stages and subsets of patients along with their potential complications and drug interactions, utilizing the principles of host factor modification (Dosha hara) and potential broad spectrum Anti-viral (Prativisha) as envisaged by Rasa Shastra.
流行病对印度来说并不陌生。阿育吠陀医学在当时的医疗保健领域处于前沿，记录了其在流行病方面的宝贵经验，并将其称为“Janapadodhwamsa”或“Maraka”。它生动地描述了它们的病因机制（Nidana）、影响严重程度的因素以及使疾病复杂化的行为、疾病的管理和预防。本研究采用了《本集》中描述的相同模型，该模型主张宿主易感性（Nija）优于外部病原体/病毒（Agantuja），并在预防中采用相同的原则；同时采用热病模型来解释COVID - 19的不同阶段并与之相关联。它根据食医（营养原则）和药物（药物治疗）为不同阶段和亚组的患者提出管理指南，以及它们潜在的并发症和药物相互作用，利用了通过 rasa shastra 所设想的宿主因素调节（Dosha hara）原则和潜在的广谱抗病毒（Prativisha）原则。
